Califf uses budget hearing to advocate for resources, authority to monitor supply chains

A House appropriations subcommittee hearing on the proposed budget for the US Food and Drug Administration placed the agency’s commissioner, Robert M. Califf, on the hot seat, taking criticism for failing to prevent an infant formula shortage in the country. In turn, Califf used the opportunity to ask lawmakers for more resources and authority to oversee the supply chains for products the FDA regulates.